US Stock MarketDetailed Quotes

ANIP ANI Pharmaceuticals

Watchlist
  • 67.610
  • -0.750-1.10%
Close Mar 28 16:00 ET
1.47BMarket Cap-65.01P/E (TTM)

ANI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
26.20%614.38M
44.75%190.57M
12.52%148.33M
18.44%138.04M
28.70%137.43M
53.87%486.82M
39.71%131.65M
57.27%131.83M
57.81%116.55M
65.62%106.79M
Operating revenue
26.20%614.38M
44.75%190.57M
12.52%148.33M
18.44%138.04M
28.70%137.43M
53.87%486.82M
39.71%131.65M
57.27%131.83M
57.81%116.55M
65.62%106.79M
Cost of revenue
37.85%250.21M
50.28%80.28M
31.13%63.08M
36.45%57.7M
30.36%49.16M
30.79%181.51M
47.06%53.42M
46.23%48.1M
19.81%42.28M
10.03%37.71M
Gross profit
19.28%364.17M
40.98%110.29M
1.83%85.26M
8.19%80.34M
27.79%88.27M
71.90%305.3M
35.11%78.23M
64.41%83.73M
92.59%74.26M
128.69%69.08M
Operating expense
41.51%361.95M
56.73%108.97M
53.58%104.95M
23.00%74.81M
28.25%73.22M
25.79%255.77M
31.44%69.52M
31.65%68.34M
21.92%60.82M
17.36%57.09M
Selling and administrative expenses
54.39%249.64M
56.81%69.72M
88.24%79.08M
36.28%52.82M
31.68%48.02M
30.35%161.7M
33.97%44.46M
39.65%42.01M
21.28%38.76M
26.55%36.47M
Research and development costs
30.03%44.58M
68.70%16.65M
-8.93%10.13M
-1.06%7.3M
77.43%10.51M
53.62%34.29M
88.95%9.87M
45.24%11.12M
77.05%7.37M
12.32%5.92M
Depreciation amortization depletion
13.28%67.73M
48.74%22.6M
3.56%15.75M
0.05%14.7M
-0.10%14.69M
4.95%59.79M
4.90%15.19M
7.34%15.21M
6.73%14.69M
0.98%14.7M
-Depreciation and amortization
13.28%67.73M
48.74%22.6M
3.56%15.75M
0.05%14.7M
-0.10%14.69M
4.95%59.79M
4.90%15.19M
7.34%15.21M
6.73%14.69M
0.98%14.7M
Operating profit
-95.52%2.22M
-84.74%1.33M
-227.94%-19.69M
-58.87%5.53M
25.60%15.06M
292.47%49.53M
73.80%8.71M
1,673.93%15.39M
218.66%13.44M
164.99%11.99M
Net non-operating interest income expense
34.66%-17.6M
-4.68%-6.02M
63.57%-2.33M
34.42%-4.66M
40.23%-4.6M
3.96%-26.94M
23.45%-5.75M
11.92%-6.4M
-6.46%-7.1M
-16.38%-7.7M
Non-operating interest expense
-34.66%17.6M
4.68%6.02M
-63.57%2.33M
-34.42%4.66M
-40.23%4.6M
-3.96%26.94M
-23.45%5.75M
-11.92%6.4M
6.46%7.1M
16.38%7.7M
Other net income (expense)
-151.31%-6.83M
-349.75%-9.08M
-476.51%-9.47M
-189.82%-3.16M
800.24%14.88M
69.40%-2.72M
37.60%-2.02M
163.22%2.52M
-32.44%-1.09M
-152.38%-2.13M
Gain on sale of security
--6.31M
---1.99M
--1.36M
---2.71M
--9.66M
----
----
----
----
----
Special income (charges)
-255.82%-9.1M
-187.51%-5.71M
-424.58%-8.29M
65.38%-359K
351.41%5.26M
73.21%-2.56M
37.81%-1.99M
163.60%2.56M
34.66%-1.04M
-177.69%-2.09M
-Less：Restructuring and merger&acquisition
-124.20%-619K
-195.37%-1.89M
132.29%825K
-65.38%359K
-95.70%90K
-72.89%2.56M
-37.81%1.99M
-163.60%-2.56M
-29.69%1.04M
177.69%2.09M
-Less:Impairment of capital assets
--7.6M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--7.47M
--0
--7.47M
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
--5.35M
--0
--0
--0
--5.35M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
-2,436.48%-4.03M
-4,075.76%-1.38M
-6,400.00%-2.54M
-66.04%-88K
5.88%-32K
-123.73%-159K
21.43%-33K
-205.41%-39K
-106.94%-53K
61.80%-34K
Income before tax
-211.78%-22.21M
-1,553.22%-13.76M
-373.63%-31.5M
-143.57%-2.29M
1,070.21%25.34M
131.71%19.87M
116.53%947K
194.18%11.51M
127.89%5.25M
108.36%2.17M
Income tax
-437.60%-3.69M
-1,575.96%-3.49M
-566.71%-7.33M
0
881.82%7.13M
107.40%1.09M
85.99%-208K
143.37%1.57M
74.43%-996K
112.59%726K
Net income
-198.63%-18.52M
-989.70%-10.28M
-343.12%-24.17M
-136.62%-2.29M
1,165.25%18.21M
139.21%18.78M
127.22%1.16M
215.58%9.94M
141.85%6.25M
107.15%1.44M
Net income continuous Operations
-198.63%-18.52M
-989.70%-10.28M
-343.12%-24.17M
-136.62%-2.29M
1,165.25%18.21M
139.21%18.78M
127.22%1.16M
215.58%9.94M
141.85%6.25M
107.15%1.44M
Minority interest income
Net income attributable to the parent company
-198.63%-18.52M
-989.70%-10.28M
-343.12%-24.17M
-136.62%-2.29M
1,165.25%18.21M
139.21%18.78M
127.22%1.16M
215.58%9.94M
141.85%6.25M
107.15%1.44M
Preferred stock dividends
0.00%1.63M
0.00%406K
0.00%406K
0.00%407K
0.00%406K
0.00%1.63M
-0.25%406K
0.00%406K
0.00%407K
0.25%406K
Other preferred stock dividends
Net income attributable to common stockholders
-217.45%-20.15M
-1,526.17%-10.68M
-357.73%-24.57M
-146.15%-2.69M
1,623.23%17.8M
134.64%17.15M
116.11%749K
205.86%9.53M
138.08%5.84M
105.03%1.03M
Basic earnings per share
-220.93%-1.04
-2,850.00%-0.55
-376.09%-1.27
-146.67%-0.14
1,300.00%0.84
128.20%0.86
107.14%0.02
183.64%0.46
131.91%0.3
104.72%0.06
Diluted earnings per share
-222.35%-1.04
-2,850.00%-0.55
-382.22%-1.27
-148.28%-0.14
1,266.67%0.82
127.87%0.85
107.14%0.02
181.82%0.45
130.85%0.29
104.72%0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 26.20%614.38M44.75%190.57M12.52%148.33M18.44%138.04M28.70%137.43M53.87%486.82M39.71%131.65M57.27%131.83M57.81%116.55M65.62%106.79M
Operating revenue 26.20%614.38M44.75%190.57M12.52%148.33M18.44%138.04M28.70%137.43M53.87%486.82M39.71%131.65M57.27%131.83M57.81%116.55M65.62%106.79M
Cost of revenue 37.85%250.21M50.28%80.28M31.13%63.08M36.45%57.7M30.36%49.16M30.79%181.51M47.06%53.42M46.23%48.1M19.81%42.28M10.03%37.71M
Gross profit 19.28%364.17M40.98%110.29M1.83%85.26M8.19%80.34M27.79%88.27M71.90%305.3M35.11%78.23M64.41%83.73M92.59%74.26M128.69%69.08M
Operating expense 41.51%361.95M56.73%108.97M53.58%104.95M23.00%74.81M28.25%73.22M25.79%255.77M31.44%69.52M31.65%68.34M21.92%60.82M17.36%57.09M
Selling and administrative expenses 54.39%249.64M56.81%69.72M88.24%79.08M36.28%52.82M31.68%48.02M30.35%161.7M33.97%44.46M39.65%42.01M21.28%38.76M26.55%36.47M
Research and development costs 30.03%44.58M68.70%16.65M-8.93%10.13M-1.06%7.3M77.43%10.51M53.62%34.29M88.95%9.87M45.24%11.12M77.05%7.37M12.32%5.92M
Depreciation amortization depletion 13.28%67.73M48.74%22.6M3.56%15.75M0.05%14.7M-0.10%14.69M4.95%59.79M4.90%15.19M7.34%15.21M6.73%14.69M0.98%14.7M
-Depreciation and amortization 13.28%67.73M48.74%22.6M3.56%15.75M0.05%14.7M-0.10%14.69M4.95%59.79M4.90%15.19M7.34%15.21M6.73%14.69M0.98%14.7M
Operating profit -95.52%2.22M-84.74%1.33M-227.94%-19.69M-58.87%5.53M25.60%15.06M292.47%49.53M73.80%8.71M1,673.93%15.39M218.66%13.44M164.99%11.99M
Net non-operating interest income expense 34.66%-17.6M-4.68%-6.02M63.57%-2.33M34.42%-4.66M40.23%-4.6M3.96%-26.94M23.45%-5.75M11.92%-6.4M-6.46%-7.1M-16.38%-7.7M
Non-operating interest expense -34.66%17.6M4.68%6.02M-63.57%2.33M-34.42%4.66M-40.23%4.6M-3.96%26.94M-23.45%5.75M-11.92%6.4M6.46%7.1M16.38%7.7M
Other net income (expense) -151.31%-6.83M-349.75%-9.08M-476.51%-9.47M-189.82%-3.16M800.24%14.88M69.40%-2.72M37.60%-2.02M163.22%2.52M-32.44%-1.09M-152.38%-2.13M
Gain on sale of security --6.31M---1.99M--1.36M---2.71M--9.66M--------------------
Special income (charges) -255.82%-9.1M-187.51%-5.71M-424.58%-8.29M65.38%-359K351.41%5.26M73.21%-2.56M37.81%-1.99M163.60%2.56M34.66%-1.04M-177.69%-2.09M
-Less：Restructuring and merger&acquisition -124.20%-619K-195.37%-1.89M132.29%825K-65.38%359K-95.70%90K-72.89%2.56M-37.81%1.99M-163.60%-2.56M-29.69%1.04M177.69%2.09M
-Less:Impairment of capital assets --7.6M------------------0----------------
-Less:Other special charges --7.47M--0--7.47M----------------------------
-Gain on sale of property,plant,equipment --5.35M--0--0--0--5.35M--0--0--0--0--0
Other non- operating income (expenses) -2,436.48%-4.03M-4,075.76%-1.38M-6,400.00%-2.54M-66.04%-88K5.88%-32K-123.73%-159K21.43%-33K-205.41%-39K-106.94%-53K61.80%-34K
Income before tax -211.78%-22.21M-1,553.22%-13.76M-373.63%-31.5M-143.57%-2.29M1,070.21%25.34M131.71%19.87M116.53%947K194.18%11.51M127.89%5.25M108.36%2.17M
Income tax -437.60%-3.69M-1,575.96%-3.49M-566.71%-7.33M0881.82%7.13M107.40%1.09M85.99%-208K143.37%1.57M74.43%-996K112.59%726K
Net income -198.63%-18.52M-989.70%-10.28M-343.12%-24.17M-136.62%-2.29M1,165.25%18.21M139.21%18.78M127.22%1.16M215.58%9.94M141.85%6.25M107.15%1.44M
Net income continuous Operations -198.63%-18.52M-989.70%-10.28M-343.12%-24.17M-136.62%-2.29M1,165.25%18.21M139.21%18.78M127.22%1.16M215.58%9.94M141.85%6.25M107.15%1.44M
Minority interest income
Net income attributable to the parent company -198.63%-18.52M-989.70%-10.28M-343.12%-24.17M-136.62%-2.29M1,165.25%18.21M139.21%18.78M127.22%1.16M215.58%9.94M141.85%6.25M107.15%1.44M
Preferred stock dividends 0.00%1.63M0.00%406K0.00%406K0.00%407K0.00%406K0.00%1.63M-0.25%406K0.00%406K0.00%407K0.25%406K
Other preferred stock dividends
Net income attributable to common stockholders -217.45%-20.15M-1,526.17%-10.68M-357.73%-24.57M-146.15%-2.69M1,623.23%17.8M134.64%17.15M116.11%749K205.86%9.53M138.08%5.84M105.03%1.03M
Basic earnings per share -220.93%-1.04-2,850.00%-0.55-376.09%-1.27-146.67%-0.141,300.00%0.84128.20%0.86107.14%0.02183.64%0.46131.91%0.3104.72%0.06
Diluted earnings per share -222.35%-1.04-2,850.00%-0.55-382.22%-1.27-148.28%-0.141,266.67%0.82127.87%0.85107.14%0.02181.82%0.45130.85%0.29104.72%0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List